Abstract
Glucose homeostasis is primarily controlled by two opposing hormones, insulin and glucagon, and diabetes results when insulin fails to inhibit glucagon action. Recent efforts to control glucagon in diabetes have focused on antagonizing the glucagon receptor, which is effective in lowering blood glucose levels but leads to hyperglucogonemia in rodents. An alternative strategy would be to control glucagon production with small molecules. In pursuit of this goal, we developed a homogeneous AlphaScreen assay for measuring glucagon in cell culture media and used this in a high-throughput screen to discover synthetic compounds that inhibited glucagon secretion from an alpha cell-like cell line. Some of these compounds inhibited transcription of the glucagon gene.
Keywords:
AlphaScreen; competition assay; diabetes; glucagon.
© 2015 Society for Laboratory Automation and Screening.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biotin / chemistry
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Cricetinae
-
Gene Expression
-
Genes, Reporter
-
Glucagon / antagonists & inhibitors*
-
Glucagon / biosynthesis
-
Glucagon / genetics
-
Glucagon-Secreting Cells / cytology
-
Glucagon-Secreting Cells / drug effects*
-
Glucagon-Secreting Cells / metabolism
-
High-Throughput Screening Assays
-
Humans
-
Hypoglycemic Agents / chemistry
-
Hypoglycemic Agents / pharmacology*
-
Kinetics
-
Luciferases / antagonists & inhibitors
-
Luciferases / genetics
-
Luciferases / metabolism
-
RNA, Messenger / antagonists & inhibitors
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Small Molecule Libraries / chemistry
-
Small Molecule Libraries / pharmacology*
-
Streptavidin / chemistry
Substances
-
Hypoglycemic Agents
-
RNA, Messenger
-
Small Molecule Libraries
-
Biotin
-
Glucagon
-
Streptavidin
-
Luciferases